Sanofi S.A. - Company Snapshot & SWOT Analysis

March 2019 | 36 pages | ID: S4ED1E8E688EN
NAVADHI Market Research Pvt Ltd

Abstracts

Sanofi S.A. is a Paris based, French multinational pharmaceutical company, focused on patient needs and engaged in the research, development, manufacture and marketing of therapeutic solutions.

The French drugmaker expected net income to increase by 3-5% in 2019 as it reported slightly higher-than-expected quarterly earnings propelled once again by its rare diseases Genzyme unit.

Sanofi’s fourth-quarter business net income was up 4.3 percent at constant exchange rates to 1.36 billion euros, while revenue rose 3.9 percent to 9 billion. Sales at Genzyme surged 37.4 percent.

Net sales in 2018 were €34,463 million, down 1.7% according to latest report. The decline is mainly due to diabetes and cardiovascular (DCV) business unit performance as unit sales were down by 11.3%;

Spanning over 36 pages and 31 exhibits, “Sanofi S.A. - Company Snapshot & SWOT Analysis” report provides value chain analysis, financial performance, business strategy and SWOT analysis for company.

Scope of the Sanofi S.A.- Company Snapshot & SWOT Analysis Report

• This report provides detailed information about Sanofi S.A. including value chain analysis, financial performance, business strategy and SWOT analysis.
• The report identifies the growth drivers and inhibitors for global pharmaceutical market.
• This report provides information about current and future trends for global pharmaceutical market.

Contents

1. EXECUTIVE SUMMARY

Scope of the Sanofi S.A.- Company Snapshot & SWOT Analysis Report
Research Methodology

2. GROWTH DRIVERS AND INHIBITORS FOR GLOBAL PHARMACEUTICALS MARKET

3. COMPANY PROFILE

3.1 Sanofi S.A.
  3.1.1. Company Profile
  3.1.2 Sanofi S.A. in Global Pharmaceuticals Manufacturing Value Chain
  3.1.3 Sanofi S.A.: Financial Performance
    3.1.3.1 Sanofi S.A.: Geography wise Performance
  3.1.4 Sanofi S.A.: Business Strategy
    3.1.4.1 Sanofi S.A. Revenue by Global Business Units (GBU’s)
    3.1.4.2 Sanofi S.A. Revenue by Global Franchise
  3.1.5 SWOT Analysis of Sanofi S.A.
Strengths
Weaknesses
Opportunities
Threats
  3.1.6 Sanofi’s TOP 10 Blockbusters Drugs Revenue in FY 2018 (in Euro millions)

4. CURRENT AND FUTURE TRENDS IN PHARMACEUTICAL MARKET

Notes
Company Information

List Of Exhibits

LIST OF EXHIBITS

Exhibit 2.1 Growth Drivers and Inhibitors for Global Pharmaceuticals Market
Exhibit 3.1 Key Information of Sanofi S.A.
Exhibit 3.2 Contact Information of Sanofi S.A.
Exhibit 3.3 Sanofi S.A. in Global Pharmaceuticals Manufacturing Value Chain
Exhibit 3.4 Sanofi S.A. Revenue FY2014-2019 (in Euro billion)
Exhibit 3.5 Year-wise Sanofi S.A. Growth 2014-19 (in %)
Exhibit 3.6 Geography-wise Sanofi S.A. Revenue Share FY 2018 (in %)
Exhibit 3.7 Geography-wise Sanofi S.A. Revenue FY 2017-2018 (in Euro million)
Exhibit 3.8 Global Business Units (GBU’s)-wise Sanofi S.A. Revenue FY 2018 (in %)
Exhibit 3.9 Global Business Units (GBU’s)-wise Sanofi S.A. Revenue FY 2017-2018 (in Euro million)
Exhibit 3.10 Global Franchise-wise Sanofi S.A. Revenue FY 2018 (in %)
Exhibit 3.11 Global Franchise-wise Sanofi S.A. Revenue FY 2017-2018 (in Euro million)
Exhibit 3.12 Sanofi S.A. Specialty Care Franchise Revenue FY 2018 (in %)
Exhibit 3.13 Sanofi S.A. Specialty Care Franchise Revenue FY 2015-2018 (in Euro million)
Exhibit 3.14 Sanofi S.A. Rare Diseases Franchise Revenue FY 2017-2018 (in Euro million)
Exhibit 3.15 Sanofi S.A. Multiple Sclerosis Franchise Revenue FY 2017-2018 (in Euro million)
Exhibit 3.16 Sanofi S.A. Oncology Franchise Revenue FY 2017-2018 (in Euro million)
Exhibit 3.17 Sanofi S.A. Immunology Franchise Revenue FY 2017-2018 (in Euro million)
Exhibit 3.18 Sanofi S.A. Rare Blood Disorder Franchise Revenue FY 2017-2018 (in Euro million)
Exhibit 3.19 Sanofi S.A. Diabetes and Cardiovascular (DCV) Franchise Revenue FY 2015-2018 (in Euro million)
Exhibit 3.20 Sanofi S.A. Diabetes Franchise Revenue By Brands FY 2017-2018 (in Euro million)
Exhibit 3.21 Sanofi S.A. Cardiovascular Franchise Revenue By Brands FY 2017-2018 (in Euro million)
Exhibit 3.22 Sanofi S.A. Established Rx Products Franchise Revenue FY 2015-2018 (in Euro million)
Exhibit 3.23 Sanofi S.A. Established Rx Products Franchise Revenue By Brands FY 2017-2018 (in Euro million)
Exhibit 3.24 Sanofi S.A. Consumer Healthcare (CHC) Franchise Revenue FY 2015-2018 (in Euro million)
Exhibit 3.25 Sanofi S.A. Consumer Healthcare (CHC) Franchise Revenue By Brands FY 2017-2018 (in Euro million)
Exhibit 3.26 Sanofi S.A. Generic Franchise Revenue FY 2015-2018 (in Euro million)
Exhibit 3.27 Sanofi S.A. Vaccines Franchise Revenue FY 2015-2018 (in Euro million)
Exhibit 3.28 Sanofi S.A. Vaccines Franchise Revenue By Brands FY 2017-2018 (in Euro million)
Exhibit 3.29 SWOT Analysis of Sanofi S.A.
Exhibit 3.30 Top 10 Blockbuster Drug Revenue of Sanofi (in Euro millions)